Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,655 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Durham NC, Baltimore MD, Savannah GA, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

Radiation Therapy and Thymus Function in Young Women With Breast Cancer

for
Breast Cancer
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18 - 50

Code: NCT07725172

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Durham NC, Fairfax VA, Baltimore MD, Pittsburgh PA,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

for
Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma,
Location: Durham NC, Charleston SC, Greenville SC, Fairfax VA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06084481

Phase 1, Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Durham NC, Myrtle Beach SC, Atlanta GA, Middletown NJ,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: Durham NC, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase 2, Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Durham NC, Fairfax VA, Philadelphia PA, Atlanta GA,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase 1, Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for
Metastatic Castration-resistant Prostate Cancer,
Location: Durham NC, Myrtle Beach SC, Columbus OH, New York NY,
Sponsor: K36 Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07103018

Phase 1, Recruiting

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

for
Follicular Lymphoma
Location: Durham NC, Lexington KY, Cleveland OH, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07634471

Phase 2, Phase 3, Recruiting

Behavioral Pain Intervention for Older Cancer Patients

for
Breast Cancer
Location: Durham NC
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 55+

Code: NCT07300995

Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Durham NC, Baltimore MD, Atlanta GA, East Brunswick NJ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07621718

Phase 3, Recruiting

Improving Outcomes in Early Menopause After Cancer

for
Early Menopause, Cancer, Premature Menopause,
Location: Durham NC
Sponsor: Duke University

Sex: Female

Age: 18 - 44

Code: NCT06982677

Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Durham NC, Fairfax VA, Philadelphia PA, Atlanta GA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors

for
Cancer, Youth Cancer, Young Adult Cancer,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 19 - 25

Code: NCT06732375

Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma,
Location: Durham NC, Fairfax VA, Atlanta GA, New Brunswick NJ,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07488676

Phase 1, Phase 2, Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for
Breast Neoplasms
Location: Durham NC, Midlothian VA, Greenville SC, Winchester VA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06926868

Phase 2, Phase 3, Recruiting

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

for
Cancer, Breast Cancer, Colorectal Cancer, Sarcoma, Lymphoma,
Location: Durham NC
Sponsor: Duke University

Sex: All

Age: 18 - 39

Code: NCT06371768

Recruiting

Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)

for
Renal Cell Carcinoma
Location: Durham NC, Pittsburgh PA, New York NY, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70+

Code: NCT07049926

Phase 1, Phase 2, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: Durham NC, Charlottesville VA, Charleston SC,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase 1, Phase 2, Recruiting

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

for
Advanced Solid Tumor, Homologous Recombination Deficiency,
Location: Durham NC, Shreveport LA, Houston TX, Seattle WA
Sponsor: Eisbach Bio GmbH

Sex: All

Age: 18+

Code: NCT06525298

Phase 1, Phase 2, Recruiting